Korean Market
EXCH
INBIOGEN
★★

INBIOGEN Files Governance Report: Director Appointments Rejected and Multiple Non-Compliance Issues Highlight Governance Risks

 
EXCH
INBIOGEN
★

Correction of Extraordinary General Meeting Date (6/5→6/30) and Convening Resolution

 
PERI
INBIOGEN
★★★

Inbiogen Q1 Net Loss Widens on Revenue Drop and Equity Method Loss